Cavalli et al. [26] identified three main subgroups of group 4 medulloblastoma: group 4α, featuring MYCN amplification; group 4β, characterized by SNCAIP duplication; and group 4γ, displaying cyclin-dependent kinase 6 (CDK6) amplification. The gene discussed is SNCAIP; the disease is medulloblastoma.